Modulation of tumor vasculature [24], down-regulation of MGMT expression [21, 23] and induction of apoptosis by IFN-β independently of MGMT-mediated resistance to temozolomide [25–27] have been discussed as mechanisms of this anti-glioma effect. This evidence concerns the gene MGMT and central nervous system cancer.